Piperacillin–tazobactam as alternative to carbapenems for ICU patients

Piperacillin–tazobactam as alternative to carbapenems for ICU patients

Abstract Several studies suggest that alternatives to carbapenems, and particulary beta-lactam/beta-lactamase inhibitor combinations, can be used for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE)-related infections in non-ICU patients. Little is known concerning...

Full description

Bibliographic Details
Main Authors: Benoit Pilmis, Vincent Jullien, Alexis Tabah, Jean-Ralph Zahar, Christian Brun-Buisson
Format: Article
Language:English
Published: SpringerOpen 2017-11-01
Series:Annals of Intensive Care
Subjects:
Carbapenems
ESBL
Alternatives
Ecological consequences
Outcome
Online Access:http://link.springer.com/article/10.1186/s13613-017-0334-x

Internet

http://link.springer.com/article/10.1186/s13613-017-0334-x

Similar Items